Saudi Arabia laboratory developed tests market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

The Saudi Arabia Laboratory Developed Tests market, valued at USD 130 million, is growing due to rising chronic diseases and emphasis on personalized medicine.

Region:Middle East

Author(s):Shubham

Product Code:KRAA8679

Pages:82

Published On:November 2025

About the Report

Base Year 2024

Saudi Arabia Laboratory Developed Tests Market Overview

  • The Saudi Arabia Laboratory Developed Tests Market is valued at USD 130 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases such as cancer and diabetes, advancements in molecular diagnostics and immunoassays, and a growing emphasis on personalized medicine. The rising demand for accurate and timely diagnostic tests has further propelled the market, as healthcare providers seek to enhance patient outcomes through innovative testing solutions. Additionally, high unmet clinical needs and increased healthcare investments are contributing to market expansion.
  • Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure and concentration of medical facilities. Riyadh, being the capital, hosts numerous hospitals and research institutions, while Jeddah serves as a major commercial hub with a high demand for diagnostic services. Dammam, with its strategic location, supports the healthcare needs of the Eastern Province, contributing significantly to the market's growth.
  • In 2023, the Saudi Food and Drug Authority (SFDA) implemented the "Regulation for Laboratory Developed Tests, 2023" issued by the Saudi Food and Drug Authority. This regulation requires all laboratory-developed tests to undergo a rigorous validation process before being offered to patients, including performance evaluation, documentation, and periodic review. Laboratories must comply with these standards to ensure the safety and efficacy of diagnostic tests, thereby enhancing the overall quality of healthcare services in the country. Compliance with these regulations is essential for laboratories to maintain their operational licenses and market presence.
Saudi Arabia Laboratory Developed Tests Market Size

Saudi Arabia Laboratory Developed Tests Market Segmentation

By Test Type:The market is segmented into various test types, including Clinical Chemistry and Immunology, Molecular Diagnostics, Hematology and Coagulation, Microbiology, Histology/Cytology, Flow Cytometry, and Mass Spectroscopy. Among these, Clinical Chemistry and Immunology is the leading segment due to its extensive application in routine diagnostics and the growing demand for biochemical tests. The increasing prevalence of metabolic disorders and the need for timely disease detection further bolster this segment's dominance. Molecular Diagnostics is also experiencing rapid growth, driven by technological advancements and the rising burden of genetic and infectious diseases.

Saudi Arabia Laboratory Developed Tests Market segmentation by Test Type.

By End-User:The market is segmented by end-users, including Hospital-Based Labs, Diagnostic Laboratories, Research Institutions, and Others. Hospital-Based Labs dominate the market due to their comprehensive testing capabilities and the increasing number of patients seeking diagnostic services. The integration of advanced technologies in these labs enhances their efficiency and accuracy, making them the preferred choice for healthcare providers. Diagnostic Laboratories are also expanding rapidly, supported by collaborations with international organizations and the adoption of new testing platforms.

Saudi Arabia Laboratory Developed Tests Market segmentation by End-User.

Saudi Arabia Laboratory Developed Tests Market Competitive Landscape

The Saudi Arabia Laboratory Developed Tests Market is characterized by a dynamic mix of regional and international players. Leading participants such as Al Borg Laboratories, King Faisal Specialist Hospital & Research Centre, Eurofins Scientific, Mayo Clinic Laboratories, Dr. Sulaiman Al Habib Medical Group, Saudi German Hospitals Group, Al Nahdi Medical Company, Al-Dar Medical Services, Dallah Hospital, Al-Moosa Specialist Hospital, Al-Salam International Hospital, Saudi Biotech Company contribute to innovation, geographic expansion, and service delivery in this space.

Al Borg Laboratories

1998

Jeddah, Saudi Arabia

King Faisal Specialist Hospital & Research Centre

1975

Riyadh, Saudi Arabia

Eurofins Scientific

1987

Luxembourg

Mayo Clinic Laboratories

1973

Rochester, Minnesota, USA

Dr. Sulaiman Al Habib Medical Group

1995

Riyadh, Saudi Arabia

Company

Establishment Year

Headquarters

Company Size (Large, Medium, or Small)

Revenue Growth Rate (CAGR %)

Market Penetration Rate (%)

Test Portfolio Breadth (Number of Test Types Offered)

Geographic Coverage (Regional Presence)

Regulatory Certifications and Accreditations

Saudi Arabia Laboratory Developed Tests Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Chronic Diseases:The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the laboratory developed tests market in Saudi Arabia. According to the Saudi Ministry of Health, approximately 8 million people are living with diabetes, and cardiovascular diseases account for 38% of all deaths in the country. This growing patient population necessitates advanced diagnostic solutions, thereby increasing the demand for laboratory developed tests that can provide timely and accurate results.
  • Rising Demand for Personalized Medicine:The shift towards personalized medicine is transforming the healthcare landscape in Saudi Arabia. The Ministry of Health reported that personalized medicine could improve treatment outcomes for 65% of patients with chronic diseases. This trend is driving the demand for laboratory developed tests that can tailor treatments based on individual genetic profiles, leading to more effective healthcare solutions and better patient management strategies.
  • Advancements in Diagnostic Technologies:Technological advancements in diagnostics are propelling the laboratory developed tests market forward. The introduction of next-generation sequencing (NGS) and molecular diagnostics has revolutionized disease detection. In future, the Saudi government plans to invest over SAR 1.5 billion in healthcare technology, which will enhance the capabilities of local laboratories to develop innovative tests, thus improving diagnostic accuracy and efficiency in patient care.

Market Challenges

  • Stringent Regulatory Requirements:The laboratory developed tests market in Saudi Arabia faces significant challenges due to stringent regulatory requirements. The Saudi Food and Drug Authority (SFDA) has implemented rigorous guidelines for test validation and approval, which can delay the introduction of new tests. In future, the SFDA is expected to increase its oversight, making compliance more complex and costly for developers, potentially stifling innovation in the sector.
  • High Costs of R&D:The high costs associated with research and development (R&D) present a formidable challenge for laboratory developed tests. According to industry reports, R&D expenditures can exceed SAR 600 million for comprehensive test development. This financial burden can deter smaller companies from entering the market, limiting competition and innovation, which is crucial for advancing diagnostic capabilities in Saudi Arabia's healthcare system.

Saudi Arabia Laboratory Developed Tests Market Future Outlook

The future of the laboratory developed tests market in Saudi Arabia appears promising, driven by technological advancements and a growing emphasis on personalized healthcare. As the healthcare infrastructure expands, more laboratories will be equipped to develop innovative tests. Additionally, the integration of artificial intelligence in diagnostics is expected to enhance test accuracy and efficiency. These trends will likely lead to increased adoption of laboratory developed tests, improving patient outcomes and driving market growth in the coming years.

Market Opportunities

  • Expansion of Healthcare Infrastructure:The Saudi government is investing heavily in healthcare infrastructure, with plans to build 35 new hospitals in future. This expansion will create opportunities for laboratory developed tests, as more facilities will require advanced diagnostic solutions to meet the growing patient demand and improve healthcare delivery.
  • Growth in Telemedicine and Remote Diagnostics:The rise of telemedicine in Saudi Arabia presents a unique opportunity for laboratory developed tests. With an estimated 70% increase in telehealth consultations since the onset of the COVID-19 pandemic, there is a growing need for remote diagnostic solutions. This trend will facilitate the development of tests that can be conducted at home, enhancing patient access to healthcare services and driving market growth.

Scope of the Report

SegmentSub-Segments
By Test Type

Clinical Chemistry and Immunology

Molecular Diagnostics

Hematology and Coagulation

Microbiology

Histology/Cytology

Flow Cytometry

Mass Spectroscopy

By End-User

Hospital-Based Labs

Diagnostic Laboratories

Research Institutions

Others

By Therapeutic Area

Genetic Disorders

Infections

Oncology

Metabolic Disorders

Others

By Product Type

Consumables

Instruments

Software and Services

By Distribution Channel

Direct Tender

Direct Sales

Distributors

Online Sales

By Sample Type

Blood

Urine

Tissue

Others

By Region

Central Region

Eastern Region

Western Region

Southern Region

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Saudi Food and Drug Authority, Ministry of Health)

Manufacturers and Producers of Laboratory Developed Tests

Distributors and Retailers of Medical Devices

Healthcare Providers and Hospitals

Technology Providers and Software Developers

Industry Associations and Trade Organizations

Financial Institutions and Investment Banks

Players Mentioned in the Report:

Al Borg Laboratories

King Faisal Specialist Hospital & Research Centre

Eurofins Scientific

Mayo Clinic Laboratories

Dr. Sulaiman Al Habib Medical Group

Saudi German Hospitals Group

Al Nahdi Medical Company

Al-Dar Medical Services

Dallah Hospital

Al-Moosa Specialist Hospital

Al-Salam International Hospital

Saudi Biotech Company

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Saudi Arabia Laboratory Developed Tests Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Saudi Arabia Laboratory Developed Tests Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Saudi Arabia Laboratory Developed Tests Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of chronic diseases
3.1.2 Rising demand for personalized medicine
3.1.3 Advancements in diagnostic technologies
3.1.4 Supportive government initiatives

3.2 Market Challenges

3.2.1 Stringent regulatory requirements
3.2.2 High costs of R&D
3.2.3 Limited awareness among healthcare providers
3.2.4 Competition from commercial tests

3.3 Market Opportunities

3.3.1 Expansion of healthcare infrastructure
3.3.2 Collaborations with research institutions
3.3.3 Growth in telemedicine and remote diagnostics
3.3.4 Increasing investment in biotechnology

3.4 Market Trends

3.4.1 Shift towards point-of-care testing
3.4.2 Integration of AI in diagnostics
3.4.3 Focus on patient-centric healthcare solutions
3.4.4 Rise of home-based testing kits

3.5 Government Regulation

3.5.1 Implementation of new health policies
3.5.2 Establishment of regulatory bodies for diagnostics
3.5.3 Guidelines for laboratory accreditation
3.5.4 Compliance requirements for test validation

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Saudi Arabia Laboratory Developed Tests Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Saudi Arabia Laboratory Developed Tests Market Segmentation

8.1 By Test Type

8.1.1 Clinical Chemistry and Immunology
8.1.2 Molecular Diagnostics
8.1.3 Hematology and Coagulation
8.1.4 Microbiology
8.1.5 Histology/Cytology
8.1.6 Flow Cytometry
8.1.7 Mass Spectroscopy

8.2 By End-User

8.2.1 Hospital-Based Labs
8.2.2 Diagnostic Laboratories
8.2.3 Research Institutions
8.2.4 Others

8.3 By Therapeutic Area

8.3.1 Genetic Disorders
8.3.2 Infections
8.3.3 Oncology
8.3.4 Metabolic Disorders
8.3.5 Others

8.4 By Product Type

8.4.1 Consumables
8.4.2 Instruments
8.4.3 Software and Services

8.5 By Distribution Channel

8.5.1 Direct Tender
8.5.2 Direct Sales
8.5.3 Distributors
8.5.4 Online Sales

8.6 By Sample Type

8.6.1 Blood
8.6.2 Urine
8.6.3 Tissue
8.6.4 Others

8.7 By Region

8.7.1 Central Region
8.7.2 Eastern Region
8.7.3 Western Region
8.7.4 Southern Region

9. Saudi Arabia Laboratory Developed Tests Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Company Size (Large, Medium, or Small)
9.2.3 Revenue Growth Rate (CAGR %)
9.2.4 Market Penetration Rate (%)
9.2.5 Test Portfolio Breadth (Number of Test Types Offered)
9.2.6 Geographic Coverage (Regional Presence)
9.2.7 Regulatory Certifications and Accreditations
9.2.8 Technology Platform Capabilities
9.2.9 R&D Investment as % of Revenue
9.2.10 Customer Base Diversification Index

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Al Borg Laboratories
9.5.2 King Faisal Specialist Hospital & Research Centre
9.5.3 Eurofins Scientific
9.5.4 Mayo Clinic Laboratories
9.5.5 Dr. Sulaiman Al Habib Medical Group
9.5.6 Saudi German Hospitals Group
9.5.7 Al Nahdi Medical Company
9.5.8 Al-Dar Medical Services
9.5.9 Dallah Hospital
9.5.10 Al-Moosa Specialist Hospital
9.5.11 Al-Salam International Hospital
9.5.12 Saudi Biotech Company

10. Saudi Arabia Laboratory Developed Tests Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Education
10.1.3 Ministry of Defense
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Healthcare Sector Investments
10.2.2 Research and Development Funding
10.2.3 Technology Upgrades
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Diagnostic Laboratories
10.3.3 Research Institutions
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Infrastructure Readiness
10.4.3 Technology Acceptance
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 User Feedback Mechanisms
10.5.3 Future Use Cases
10.5.4 Others

11. Saudi Arabia Laboratory Developed Tests Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail vs Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from health authorities in Saudi Arabia
  • Review of scientific publications and journals on laboratory developed tests (LDTs)
  • Examination of regulatory frameworks and guidelines from the Saudi Food and Drug Authority (SFDA)

Primary Research

  • Interviews with laboratory directors and managers in leading healthcare institutions
  • Surveys with healthcare professionals involved in diagnostic testing
  • Focus groups with industry experts and stakeholders in the LDT market

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including government reports and industry publications
  • Triangulation of insights from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel discussions and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the overall healthcare expenditure in Saudi Arabia as a basis for LDT market size
  • Segmentation of the market by types of tests and healthcare settings (hospitals, clinics, etc.)
  • Incorporation of growth rates from related sectors such as biotechnology and personalized medicine

Bottom-up Modeling

  • Collection of data on the number of LDTs offered by major laboratories in the region
  • Estimation of average pricing for various types of laboratory developed tests
  • Calculation of market size based on volume of tests performed and associated revenues

Forecasting & Scenario Analysis

  • Utilization of historical growth trends to project future market developments
  • Scenario analysis based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Clinical Laboratories100Laboratory Managers, Quality Assurance Officers
Healthcare Providers70Physicians, Diagnostic Test Coordinators
Regulatory Bodies40Regulatory Affairs Specialists, Compliance Officers
Research Institutions60Research Scientists, Clinical Researchers
Industry Associations50Policy Makers, Industry Analysts

Frequently Asked Questions

What is the current value of the Saudi Arabia Laboratory Developed Tests Market?

The Saudi Arabia Laboratory Developed Tests Market is valued at approximately USD 130 million, reflecting a significant growth driven by the increasing prevalence of chronic diseases, advancements in diagnostic technologies, and a focus on personalized medicine.

What are the main factors driving growth in the Saudi Arabia Laboratory Developed Tests Market?

Which cities are the primary markets for laboratory developed tests in Saudi Arabia?

What regulations govern laboratory developed tests in Saudi Arabia?

Other Regional/Country Reports

Middle East Laboratory Developed Tests Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030Saudi Arabia Pacific Laboratory Developed Tests Market

Indonesia Laboratory Developed Tests Market

Malaysia Laboratory Developed Tests Market

APAC Laboratory Developed Tests Market

SEA Laboratory Developed Tests Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022